Stryker Corporation (SYK) Stock Price & AI Analysis

$379.75
-$9.82
(2.52%)
Health Care Equipment

NYSE USA

May 22, 3:27 PM EDT
  • Market Cap.
    145.13B
  • Volume
    1.45M
  • Avg. Volume
    1.66M
  • Target Price
    $430.54
  • 52W Range
    314.93 - 406.19
  • RSI (14)
    51.63
  • Beta
    0.93
  • PEG Ratio
    4.72
  • SMA 20
    -0.1700%
  • SMA 50
    2.94%
  • SMA 200
    2.83%
  • Insider Owner
    6.46%
  • Insider Trans
    -1.61%
  • Institution Owner
    80.45%
  • Institution Trans
    0.67%
  • Short Interest
    5.73%
  • EPS next Y
    11.15

Stryker Corporation Company Profile

Stryker Corp. is a medical technology company, which engages in the provision of products and services that help improve patient and healthcare outcomes. It operates under the MedSurg and Neurotechnology, and Orthopaedics and Spine segments. The MedSurg and Neurotechnology segment includes surgical equipment and navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment, intensive care disposable products, clinical communication, workflow solutions, products for the treatment of acute ischemic and hemorrhagic stroke, traditional brain, and open skull based surgical procedures, orthobiologic, and biosurgery. The Orthopaedics and Spine segment focuses on implants used in hip and knee joint replacements and trauma and extremity surgeries, and cervical, thoracolumbar, and interbody systems used in spinal injury, deformity, and degenerative therapies. The company was founded by Homer H. Stryker in 1941 and is headquartered in Portage, MI.
Stryker Corp. is a medical technology company, which engages in the provision of products and services that help improve patient and healthcare outcomes. It operates under the MedSurg and Neurotechnology, and Orthopaedics and Spine segments. The MedSurg and Neurotechnology segment includes surgical equipment and navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment, intensive care disposable products, clinical communication, workflow solutions, products for the treatment of acute ischemic and hemorrhagic stroke, traditional brain, and open skull based surgical procedures, orthobiologic, and biosurgery. The Orthopaedics and Spine segment focuses on implants used in hip and knee joint replacements and trauma and extremity surgeries, and cervical, thoracolumbar, and interbody systems used in spinal injury, deformity, and degenerative therapies. The company was founded by Homer H. Stryker in 1941 and is headquartered in Portage, MI.

Stryker Corporation | Latest news

Stryker Unveils Next-Generation Mako SmartRobotics but Stock Falls

SYK unveils next-gen Mako SmartRobotics, revolutionizing hip, knee and spine surgeries with greater...

Zacks - 2 months ago

Stryker Corporation (SYK): A Bull Case Theory

We came across a bullish thesis on Stryker Corporation (SYK) on Substack by Magnus Ofstad. In this article, we will summarize the bulls’ thesis on SYK....

Insider Monkey - 1 month ago

SYK Stock Rises Following the Launch of Next Generation SurgiCount+

Stryker Corporation SYK has announced the launch of the next generation of SurgiCount+ within its...

Zacks - 6 months ago

Reasons to Retain Stryker (SYK) Stock in Your Portfolio Now

Stryker Corporation SYK is well poised for growth, backed by a robust robotic arm-assisted surgery...

Zacks - 1 year ago

Stryker Corporation (SYK): Leading the Charge in Robotic-Assisted Surgery

We recently published a list of 8 Most Promising Robotics Stocks According to Hedge Funds. In this...

Insider Monkey - 6 months ago

Stryker Corporation (SYK): AI-Driven Innovations and Strategic Acquisitions...

We recently published a list of 10 Best Medical Stocks to Buy Now. In this article, we are going to...

Insider Monkey - 7 months ago

Stryker (SYK) Gains 11.6% YTD: What's Driving the Stock?

Stryker Corporation SYK witnessed substantial gains in the year-to-date period. Shares of the...

Zacks - 10 months ago

Stryker's (SYK) Q4 Earnings & Revenues Surpass Estimates

Stryker's (SYK) fourth-quarter earnings reflect strong performance across its segments and...

Zacks - 1 year ago

Here's Why You Should Retain Stryker (SYK) Stock for Now

Stryker (SYK) continues to benefit from strength in the robotic arm-assisted surgery platform, Mako,...

Zacks - 2 years ago

Stryker (SYK) Acquires SERF SAS to Aid Its Orthopedic Segment

Stryker (SYK) completes its acquisition of SERF SAS, a France-based joint replacement company. With...

Zacks - 1 year ago